secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001213900-26-033842
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex partners with AASM Foundation, sponsors junior investigator sleep apnea grant
--------------------------------------------------------------------------------

- Partnership with AASM Foundation Corporate Recognition Program to support sleep apnea research.
- Sponsors a Focused Projects Grant for Junior Investigators in Diagnosis, Management, and Treatment of Sleep Apnea, to be awarded in 2026.
- IHL-42X Phase 2 DReAMzz study patient dosing expected within coming months; Phase 3 pathway defined.
- Previous milestones: positive Phase 2 results, FDA Fast Track designation, and establishment of Clinical Advisory Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390026033842/0001213900-26-033842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390026033842/ea028334201-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-033842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer